Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
65
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Downregulated level of insulin in COPD patients during AE; role beyond glucose control?

Wenjing Ruan1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Chao Yan1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Huiqi Zhu1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Shuwen Wang1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Xuan Jia1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Lingyan Shao1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China
,
Zhihao Xu2 Department of Respiratory Diseases, The Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, People’s Republic of China
&
Kejing Ying1 Department of Respiratory Diseases, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1559-1566 | Published online: 15 Jul 2019

References

  • Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):1052–1064. doi:10.1164/rccm.201401-0058OC24617842
  • Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One. 2016;11(7):e0158843. doi:10.1371/journal.pone.015884327434033
  • Ruan W, Wu M, Shi L, et al. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:1775–1780. doi:10.2147/COPD.S13265228684903
  • Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem. 1997;272(49):30729–30734. doi:10.1074/jbc.272.49.307299388210
  • Ye M, Yu H, Yu W, et al. Evaluation of the significance of circulating insulin-like growth factor-1 and C-reactive protein in patients with chronic obstructive pulmonary disease. J Int Med Res. 2012;40(3):1025–1035. doi:10.1177/14732300120400032122906275
  • Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
  • Araki E, Yamashita S, Arai H, et al. Effects of pemafibrate, a novel selective pparalpha modulator, on lipid and glucose metabolism in patients with type 2 diabetes and hypertriglyceridemia: a randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Care. 2018;41(3):538–546. doi:10.2337/dc17-158929298800
  • Singh S, Bodas M, Bhatraju NK, et al. Hyperinsulinemia adversely affects lung structure and function. Am J Physiol Lung Cell Mol Physiol. 2016;310(9):L837–L845. doi:10.1152/ajplung.00091.201526919895
  • Dekkers BG, Schaafsma D, Tran T, Zaagsma J, Meurs H. Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype. Am J Respir Cell Mol Biol. 2009;41(4):494–504. doi:10.1165/rcmb.2008-0251OC19213874
  • Siekmeier R, Scheuch G. Inhaled insulin–does it become reality? J Physiol Pharmacol. 2008;59(Suppl 6):81–113.
  • Guevara CA. Inhaled insulin for diabetes mellitus. N Engl J Med. 2007;356(20):2106–2107. author reply 2108.
  • Fruchter O, Yigla M, Kramer MR. Lipid profile and statin use: the paradox of survival after acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci. 2015;349(4):338–343. doi:10.1097/MAJ.000000000000043525719977
  • Lee H, Kim SR, Oh Y, Cho SH, Schleimer RP, Lee YC. Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma. Am J Respir Cell Mol Biol. 2014;50(4):667–677. doi:10.1165/rcmb.2013-0397TR24219511
  • Lee YC, Jogie-Brahim S, Lee DY, et al. Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-kappaB signaling through IGFBP-3R-mediated activation of caspases. J Biol Chem. 2011;286(20):17898–17909. doi:10.1074/jbc.M111.23103521383009

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.